Principal Engineer, Enterprise Data Integration
US$179,500 – US$227,000 / yr base salary
Posted 21 Aug 2026
Advertised as “Principal Engineer, Enterprise Data Integration / Associate Director”
BranchFactor Summary
The original posting with the fluff stripped out
- Expected experience
- 7–10 yrs
- Management level
- People management
- Employment
- Hybrid
- Contract
- Full-time
| Base salary | US$179,500 – US$227,000 / yr |
|---|
Field of studyBusiness Administration, Computer Science, Data Engineering, Engineering, Information Systems
Study levelBachelor's or higher
Who We Are:
Xenon Pharmaceuticals (NASDAQ:XENE) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.
What We Do:
We are advancing an exciting product pipeline to address indications with high unmet medical need, including epilepsy, depression and pain. Our Phase 3 azetukalner program represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we submitted a New Drug Application to the Food and Drug Administration in the third quarter of 2026. Our Phase 3 epilepsy program also includes a second FOS study, X-TOLE3, which would support regulatory submissions outside the U.S., and the X-ACKT study in primary generalized tonic-clonic seizures, which would support regulatory submissions for an additional epilepsy indication. We also have multiple Phase 3 azetukalner clinical trials underway in major depressive disorder (MDD) and bipolar depression (BPD), based on topline data from our Phase 2 X-NOVA clinical trial. In addition, we are proud of our strong heritage in human genetics, deep understanding of ion channel biology, and expertise in novel chemistries to enable potent, selective ion channel targeting. We continue to advance an early-stage pipeline of novel therapeutic candidates, including Phase 1 studies for XEN1701 and XEN1720 (targeting Nav1.7) and XEN1120 (targeting Kv7), which are being developed for pain. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.
About the Role:
We are seeking a Principal Engineer, Enterprise Data Integration, to join our Information Technology (IT) team. The position will help lead the design, implementation, and ongoing operation of Xenon’s enterprise integration, middleware, and data engineering capabilities. This individual will partner with leaders across IT, Commercial, Medical, Finance, Supply Chain, Clinical Development, Research, and Quality, and external partners to establish scalable, secure, and compliant data flows across Xenon’s enterprise application and analytics ecosystem.